MedPath

: Effect of adding adjuvant dexmedetomidine to local anaesthesia for vitreoretinal surgery

Not Applicable
Completed
Conditions
Health Condition 1: H338- Other retinal detachmentsHealth Condition 2: H330- Retinal detachment with retinal breakHealth Condition 3: H356- Retinal hemorrhageHealth Condition 4: H334- Traction detachment of retina
Registration Number
CTRI/2019/07/020225
Lead Sponsor
arayana Nethralaya
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
100
Inclusion Criteria

100 ASA I-III adult patients aged greater than 18 years, undergoing vitreoretinal surgery under peribulbar block will be included in the study after obtaining a written informed consent. All patients will undergo routine pre-operative evaluation for vitreoretinal surgery.

Exclusion Criteria

Patients with history of hypersensitivity to the study drugs, significant cardiovascular disease (second [Mobitz II type] or third degree heart block, obstructive sleep apnea, chronic clonidine therapy, coagulopathy, impaired mental status, refusal to use local anaesthestic technique and pregnancy will be excluded from the study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The primary outcome is the requirement of supplementation of peribulbar block prior to or during the surgery.Timepoint: 0,1,2,3,4,5,10, 15 min and every 15 min till end of surgery
Secondary Outcome Measures
NameTimeMethod
2. The secondary outcome is the post-operative analgesic requirement.Timepoint: 1h,2h,6h,24h post op
© Copyright 2025. All Rights Reserved by MedPath